Clinical trial
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect (ATAX)
NCT03769961 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect (ATAX)
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 1, 2018
- Completion date
- September 14, 2020
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ataxia, cerebellar diseases, deep brain stimulation, essential tremor